Wouter Zandee

  1. 2021
  2. 2020
  3. Merola, E., Alonso Gordoa, T., Zhang, P., Al-Toubah, T., Pellè, E., Kolasińska-Ćwikła, A., Zandee, W., Laskaratos, F., de Mestier, L., Lamarca, A., Hernando, J., Cwikla, J., Strosberg, J., de Herder, W., Caplin, M., Cives, M., & van Leeuwaarde, R. (2020). Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%? The Oncologist, 1-8. [onco.13633]. https://doi.org/10.1002/onco.13633
  4. Merola, E., Zandee, W. T., de Mestier, L., Klumpen, H-J., Makulik, K., Geboes, K., van Velthuysen, M-L., Couvelard, A., Cros, J., van Eeden, S., Hoorens, A., Stephenson, T., Zajęcki, W., de Herder, W. W., & Munir, A. (2020). Histopathological Revision for Gastro-Entero-Pancreatic Neuroendocrine Neoplasms in Expert Centers: Does it Make the Difference? Neuroendocrinology, 111(1-2), 170-177. https://doi.org/10.1159/000507082
  5. Refardt, J., Zandee, W. T., Brabander, T., Feelders, R. A., Franssen, G. J. H., Hofland, L. J., Christ, E., de Herder, W. W., & Hofland, J. (2020). Inferior outcome of neuroendocrine tumor patients negative on somatostatin receptor imaging. Endocrine-Related cancer, 27(11), 615-624. https://doi.org/10.1530/ERC-20-0340
  6. 2019
  7. Zandee, W. T., Feelders, R. A., Smit Duijzentkunst, D. A., Hofland, J., Metselaar, R. M., Oldenburg, R. A., van Linge, A., Kam, B. L. R., Teunissen, J. J. M., Korpershoek, E., Hendriks, J. M., Abusaris, H., Slagter, C., Franssen, G. J. H., Brabander, T., & De Herder, W. W. (2019). Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE. European Journal of Endocrinology, 181(1), 45-53. https://doi.org/10.1530/EJE-18-0901
  8. Zandee, W. T., Brabander, T., Blažević, A., Kam, B. L. R., Teunissen, J. J. M., Feelders, R. A., Hofland, J., & de Herder, W. W. (2019). Symptomatic and Radiological Response to 177Lu-DOTATATE for the Treatment of Functioning Pancreatic Neuroendocrine Tumors. Journal of Clinical Endocrinology and Metabolism, 104(4), 1336-1344. https://doi.org/10.1210/jc.2018-01991
  9. Carlsen, E. A., Fazio, N., Granberg, D., Grozinsky-Glasberg, S., Ahmadzadehfar, H., Grana, C. M., Zandee, W. T., Cwikla, J., Walter, M. A., Oturai, P. S., Rinke, A., Weaver, A., Frilling, A., Gritti, S., Arveschoug, A. K., Meirovitz, A., Knigge, U., & Sorbye, H. (2019). Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study. Endocrine-Related cancer, 26(2), 227-239. https://doi.org/10.1530/ERC-18-0424
  10. 2018
  11. Blažević, A., Zandee, W. T., Franssen, G. J. H., Hofland, J., van Velthuysen, M-L. F., Hofland, L. J., Feelders, R. A., & de Herder, W. W. (2018). Mesenteric fibrosis and palliative surgery in small intestinal neuroendocrine tumours. Endocrine-Related cancer, 25(3), 245-254. https://doi.org/10.1530/ERC-17-0282
  12. Rindi, G., Klersy, C., Albarello, L., Baudin, E., Bianchi, A., Buchler, M. W., Caplin, M., Couvelard, A., Cros, J., de Herder, W. W., Delle Fave, G., Doglioni, C., Federspiel, B., Fischer, L., Fusai, G., Gavazzi, F., Hansen, C. P., Inzani, F., Jann, H., ... Falconi, M. (2018). Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study. Neuroendocrinology, 107(4), 375-386. https://doi.org/10.1159/000494355
  13. 2017
  14. Zandee, W. T., van Adrichem, R. C., Kamp, K., Feelders, R. A., van Velthuysen, M-L. F., & de Herder, W. W. (2017). Incidence and prognostic value of serotonin secretion in pancreatic neuroendocrine tumours. Clinical Endocrinology, 87(2), 165-170. https://doi.org/10.1111/cen.13364
  15. Zandee, W. T., Alsma, J., Birkenhäger, T. K., den Meiracker, A. H. VAN., van Hoek, M., & Versmissen, J. (2017). Hypertensie en orthostatische hypotensie bij gebruik van monoamine-oxidase(MAO)-remmers1. Tijdschrift voor Psychiatrie, 59(6), 366-371.
  16. 2016
  17. 2015

ID: 122452603